Am grateful to Katie Deighton of The Wall Street Journal for her interview about the challenges we faced commercialising a completely new & innovative period care product, and our pivot to the medical devices (drug delivery) space. Understandably there hasn’t been anywhere near the press interest we had when things looked incredibly promising, to focus …
Thank you to BBC Science Focus for mentioning Calla Lily Clinical Care’s drug delivery device in their article. “One of the current problems with vaginally-inserted medications is they often result in drug leakage and increased discharge. However, one company, @Calla Lily Clinical has developed a new leak-free vaginal drug delivery platform. This device is simple …